Advertisement
Advertisement

CATX

CATX logo

Perspective Therapeutics, Inc.

4.66
USD
Sponsored
+0.03
+0.54%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

4.69

+0.04
+0.75%

CATX Earnings Reports

Positive Surprise Ratio

CATX beat 22 of 33 last estimates.

67%

Next Report

Date of Next Report
Apr 27, 2026
Estimate for Q1 26 (Revenue/ EPS)
$179.93K
/
-$0.38
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
-47.39%
/
+52.00%

Perspective Therapeutics, Inc. earnings per share and revenue

On Jan 30, 2026, CATX reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.36 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 238.25 thousand, with a --% difference. The market reacted with a +11.81% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.38 USD, with revenue projected to reach 179.93 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q4 2025, Perspective Therapeutics, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 11.81%, changed from $2.54 before the earnings release to $2.84 the day after.
The next earning report is scheduled for Apr 27, 2026.
Based on 8 analysts, Perspective Therapeutics, Inc. is expected to report EPS of -$0.38 and revenue of $179.93K for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement